¶ … Modafinil on the rate of recovery after general anesthesia before the work of Larijani et al. (2004) are rare. However, after the publication of their article, a series of articles on Modafinil followed. Galvin et at., (2010) carried out a study to prove that modafinil can effectively reduce the level of patient-reported tiredness that is experienced after sedation or analgesia. Their article however was an improvement on the work of Larijani since it also investigated the proposition that in the process of reducing the level of tiredness, the drug has no improvement on the psychomotor skills of the patient.Their article was written against a backdrop of information that suggest that the early recovery of patients who have been sedated as well as after anesthesia in the ambulatory practice. The aim of their study was to conclusively assess if modafinil employed for the treatment of narcolepsy significantly improves the recovery from analgesia/sedation. Their methodology involved the random assignment of patients who have been scheduled to undergo extracorporeal shock wave lithotripsy to one of a total of four groups. The methodology involved the administration of a combination of the drug, fentanyl/midazolam with placebo or modafinil to two groups. The remaining two groups The two groups were then compared digital by means of digital symbol substitution test (DSST), observer scale of sedation and analgesia (OAA/S),Aldete score and trail making test (TMT).The secondary variables were captured using the verbal rating scale (VRS) scores. This included variables such as energy, dizziness as well as tiredness all of which were recorded prior to and after the treatment. The outcome of their work indicated that 67% of the patients managed to complete the study successfully.The groups never had any statistically significant difference for the DSST between all the groups. For the TMT, Aldrete and OAA/S scores, no significant statistical difference was noted. The work of Galvin et al., (2010) concluded that Modafinil effectively reduces the level of patient-reported tiredness after sedation bit with no improvement on the psychomotor skills of the patient.This study therefore corroborated the work of Larijani et al.,(2004) since it indicates that the drug improves recovery of patients after anesthesia-based treatment. Doyle and Wilkinson (2008) reported a patient who was suffering from narcolepsy while undergoing a gynaecological surgery while under general anaesthesia.The symptoms in the patient were pointed out by the duo to be well controlled by the administration of modafinil therapy. The modafinil therapy was omitted at the time of her surgery.Modafinil is pointed out to be a unique drug with various interactions with multiple anaesthetic agents. Narcolepsy is a very chronic neurological condition which is characterized by uncontrollable and recurrent brief episodes of deep sleep (Dorland,2000).Modafinil has been pointed out to treat the excessive sleepiness that affects narcoleptic patients as pointed out by the U.S. Modafinil in Narcolepsy Multicenter Study Group (1998).Kumar (2008) conducted an evidence-based review of the approved as well as the investigational applications of Modafinil. He pointed out that the drug is approved by FDA for use for same-day surgery after general surgery.He pointed out that a single dose of Modafinil was administered and compared against placebo. Morimoto et al. (2011) presented a report on the management of a patient suffering from narcolepsy using anesthetics. Modafinil was used to control narcolepsy. Valentino and Foldvary-Schaefer (2007) studied the effects of Modafinil as a medication for treating excessive sleepiness.
A critique of the article "Modafinil improves recovery after general anesthesia" by Larijani et al. (2004)
Summary
The article by Larijani et (2004) discusses a situation on how Modafinil was studied in regards to how it improves the rate of recovery after exposure to general anesthesia. The article indicates that the recovery of a patient from general anesthesia usually involves sedation, fatigue, drowsiness as well as a general lack of energy. Modafinil is a drug that promotes wakefulness and has been approved by FDA for use in patients suffering from excessive daytime sleepiness as a consequence of narcolepsy. The work evaluated the influence of modafinil (200 mg) doses and placebo in various patients who were recovering from the effect of general anesthesia. A total of 34 subjects were participants in this study in a randomized as well as a double-blind study were duly approved by their IRB. The study involved the process of asking preoperative patients to rate the symptoms that they had earlier on experienced within 24 hours via a verbal analogue scale (VAS) ranging from 0 to 10. Discrete scales...
Placebos in Clinical Practice REINFORCING MIND-BODY LINK Medical dictionaries define placebo as a non-medication substance, prescribed or given to reinforce the patient's expectation to get well. Research on the effect of placebos is of great significance to healthcare professionals because of their widespread use. That widespread use draws from their effect in the improvement of a symptom or disease without specifically improving the condition under treatment. That effect, called the placebo effect,
Whether someone views something as a placebo or not from a medical standpoint, if it improves the health and well-being of a patient then it is good for that patient, and good for the medical community as a whole (Ambrose, 2007). The second reason for the health care system to allow alternative medicine is that people believe in it in the same way that they believe in placebo pills if
Placebo Drugs One of the most important factors involved in medical trials is probably ethics. Concerns like participant autonomy and informed consent are among the top priorities of the research clinician. This is why the use of placebos in clinical trials produces some murky waters, particularly with issues like the current Ebola crisis in Sub-Saharan Africa. While it is definitely acceptable to use a placebo in some cases, other cases produce
Placebos Proposition Fact (Proposition: Placebos actual benefits patients) 1. You defend a proposition fact relevant significant a future proposition policy, argue values policies essay. IMPORTANT!! 2. The essay carefully strucutured standard parts a formal essay. Proposition of Fact Placebos can have actual benefits to patients Placebos are sham or fake treatments that are given to patients, in place of actual treatment. A doctor can decide to issue this kind of treatment to a
Croop et al. (1997). The overall safety profile of naltrexone is good; however, care must be taken in prescribing the drug to certain patient populations; e.g., naltrexone shows a dose-dependent hepatotoxicity (package insert) and is therefore contraindicated in patients with significant hepatic impairment, which is frequently encountered in alcohol-dependent populations. The clinical trials of naltrexone have typically been conducted in patients without significant impairment in hepatic function. Another consequence of the hepatic
Ginko Biloba Gingko Biloba -- Part I What are the author's general conclusions (summarized) on the effectiveness of Gingko Biloba as a cognitive enhancer? According to the author, effects of Gingko on cognition are perplexing because of its dual actions as following. It's seen improving short-term memory but at the same time it impairs digit recall ability. It slows down mental decline in patients with Alzheimer's disease but has lower dose response curve
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now